Platinum-Montaur Life Sciences, LLC v. Navidea Biopharmaceuticals, Inc.
Platinum-Montaur Life Sciences, LLC |
Navidea Biopharmaceuticals, Inc. |
1:2017cv09591 |
December 6, 2017 |
US District Court for the Southern District of New York |
Foley Square Office |
Valerie E. Caproni |
Negotiable Instrument |
28 U.S.C. ยง 1332 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 50 ORDER: IT IS HEREBY ORDERED that the parties must appear for a status conference on January 24, 2020, at 10:00 A.M. (As further set forth in this Order.) (Status Conference set for 1/24/2020 at 10:00 AM before Judge Valerie E. Caproni.) (Signed by Judge Valerie E. Caproni on 12/19/2019) (cf) |
Filing 45 OPINION AND ORDER; re: 35 MOTION to Dismiss Complaint. filed by Navidea Biopharmaceuticals, Inc. For the foregoing reasons, Defendant's motion to dismiss, which the Court construes as one brought pursuant to Fed. R. Civ. P. 12( b)(1), is GRANTED without prejudice as to all claims. The Clerk of the Court is respectfully directed to terminate the case and all pending motions and deadlines therein. So Ordered. (Signed by Judge Valerie E. Caproni on 10/31/2018) (js) Transmission to Orders and Judgments Clerk for processing. |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.